Urinary tract infections are among the most common bacterial infections in the United States, but treatment options are shrinking as resistance to antibiotics commonly prescribed to treat the condition continues to rise.

Luca Biologics, a new Cambridge, MA-based biotech focused on women’s health, emerged Tuesday with a plan to advance an investigational UTI drug into human testing in the next year, along with others addressing common women’s health conditions. About half of all women will develop UTIs in their lifetimes.

The company’s name is a nod to what’s known as the “last universal common ancestor”—the microbial life form to which… Read more »